Four Decades for Justice
Cravath represented Evolent Health, Inc. in connection with its US$168 million registered secondary common stock offering. Evolent Health provides an integrated value‑based care platform to the nation’s leading health systems and physician organizations. The shares were listed on the New York Stock Exchange. The transaction closed on March 31, 2017.
The Cravath team included partner William V. Fogg, practice area attorney Elizabeth A. Morgan and associate Martin P. Pepeljugoski. Cole‑Gabriel DuMond also worked on this matter.
Deals & Cases
January 24, 2024
Cravath represented the initial purchasers in connection with the $1 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. Cravath also represented the dealer manager in connection with the concurrent $985 million cash tender offer. The high‑yield senior secured notes offering closed on December 22, 2023, and the cash tender offer closed on January 10, 2024.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.